Overview
Bayer (Monsanto) has paid over $11 billion in total to resolve Roundup/glyphosate claims (per public reports). In March 2026 the court preliminarily approved a $7.25 billion settlement covering current and future cancer claims. The fairness hearing was held on September 14, 2026 before Judge Timothy Boyer of the Circuit Court for the City of St. Louis; plaintiffs’ attorneys opposing the deal raised objections about settlement structure and attorney fees, and no ruling had been issued as of the hearing (per The New Lede, Sep 14 2026). Registration and claim submission remain closed pending final approval (per the official settlement website, Sep 2026). IARC classifies glyphosate as “probably carcinogenic to humans” (Group 2A, per IARC). Plaintiff firms continue to review new cancer claims for the future claims pool (per firm pages, 2026).
Key people
Companies involved
Settlement amounts
Bayer has paid over $11 billion in total (per public reports), including a $7.25 billion settlement covering current and future claims (per court, Mar 2026). Per-claim estimates discussed at the fairness hearing run from roughly $6,000 to $165,000+ depending on claim type (per the official settlement website); final approval pending. No outcome can be promised.
Key dates
- September 14, 2026Fairness hearing held in St. Louis Circuit Court; decision not yet issued; objections pending (per The New Lede and the official settlement website)
- March 1, 2026Preliminary approval of the $7.25 billion settlement covering current and future claims (per court order and reports)
- August 10, 2018First $469 million cancer verdict (per court records; later reduced on appeal)
- April 15, 2015IARC classifies glyphosate as “probably carcinogenic to humans” (Group 2A) (per IARC)
Updates
- Updated Sep 14, 2026Fairness hearing held Sep 14, 2026 (St. Louis Circuit Court); objections raised by opposing plaintiffs’ counsel; ruling not yet issued; registration stays closed pending final approval (per The New Lede and the official settlement website).
- Updated Aug 6, 2026Seeded from research (Aug 2026): $7.25B settlement preliminarily approved Mar 2026; fairness hearing rescheduled to Sep 14, 2026 (per the official settlement website).
Notable filings
No notable filings recorded yet. Docket entries are added from public court records as they appear.
FAQ
What is the Roundup lawsuit about?
Claimants alleged that use of Roundup (glyphosate) contributed to cancer — most often non-Hodgkin lymphoma (per complaints). The consolidated litigation was In re Roundup Insecticide Products Liability Litigation, MDL 1417, N.D. Cal. (per JPML).
How much has Bayer paid in total?
Bayer (Monsanto) has paid over $11 billion in total to resolve Roundup/glyphosate claims, including individual verdicts and settlements (per public reports).
What is the $7.25 billion settlement?
In March 2026 the court preliminarily approved a $7.25 billion settlement covering current and future claims; final approval was still pending as of August 2026, with the fairness hearing set for September 14, 2026, and registration not yet open (per the official settlement website, August 6, 2026).
Can I still file a Roundup claim?
Plaintiff firms continue to review new cancer claims for the future claims pool (per firm pages, August 2026). Whether you qualify depends on your facts — this is not legal advice.
What did IARC conclude about glyphosate?
IARC classifies glyphosate as “probably carcinogenic to humans” (Group 2A, per IARC). Other agencies have reached different conclusions; this page reports each source’s position without taking a side.
How much will I receive?
Per-claim amounts vary under the claims program; no outcome can be promised. Reported per-claim figures are case-specific and are not verified against the docket.
Think this matters to you?
This page is neutral reference material — not legal advice. If you were affected, the next step is a free case review with a licensed attorney working this matter.
Start free case review →